Jane Street’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.75M | Buy |
164,881
+38,474
| +30% | +$444K | ﹤0.01% | 5433 |
|
|
2026
Q1 | $1.29M | Buy |
+126,407
| New | +$1.36M | ﹤0.01% | 5955 |
|
|
2025
Q1 | – | Sell |
-110,917
| Closed | -$1.67M | – | 10146 |
|
|
2024
Q4 | $1.95M | Sell |
110,917
-50,172
| -31% | -$931K | ﹤0.01% | 4148 |
|
|
2024
Q3 | $3.08M | Sell |
161,089
-101,761
| -39% | -$1.96M | ﹤0.01% | 3675 |
|
|
2024
Q2 | $5.74M | Buy |
262,850
+244,253
| +1,313% | +$6.51M | ﹤0.01% | 2776 |
|
|
2024
Q1 | $713K | Sell |
18,597
-4,667
| -20% | -$226K | ﹤0.01% | 6051 |
|
|
2023
Q4 | $1.56M | Sell |
23,264
-17,529
| -43% | -$1.22M | ﹤0.01% | 4762 |
|
|
2023
Q3 | $3.05M | Buy |
40,793
+21,659
| +113% | +$1.92M | ﹤0.01% | 3342 |
|
|
2023
Q2 | $1.76M | Buy |
19,134
+9,982
| +109% | +$889K | ﹤0.01% | 4349 |
|
|
2023
Q1 | $949K | Buy |
9,152
+6,244
| +215% | +$692K | ﹤0.01% | 5093 |
|
|
2022
Q4 | $335K | Sell |
2,908
-2,093
| -42% | -$244K | ﹤0.01% | 6824 |
|
|
2022
Q3 | $542K | Buy |
5,001
+2,972
| +146% | +$426K | ﹤0.01% | 6549 |
|
|
2022
Q2 | $366K | Buy |
+2,029
| New | +$363K | ﹤0.01% | 7271 |
|
|
2022
Q1 | – | Sell |
-2,806
| Closed | -$588K | – | 10735 |
|
|
2021
Q4 | $588K | Sell |
2,806
-8,353
| -75% | -$1.73M | ﹤0.01% | 6954 |
|
|
2021
Q3 | $2.15M | Buy |
11,159
+5,688
| +104% | +$1.4M | ﹤0.01% | 4337 |
|
|
2021
Q2 | $1.55M | Sell |
5,471
-13,846
| -72% | -$3.75M | ﹤0.01% | 4856 |
|
|
2021
Q1 | $4.09M | Buy |
+19,317
| New | +$4.62M | ﹤0.01% | 2702 |
|
|
2020
Q4 | – | Sell |
-3,413
| Closed | -$603K | – | 7853 |
|
|
2020
Q3 | $561K | Buy |
+3,413
| New | +$562K | ﹤0.01% | 4972 |
|
|
2020
Q1 | – | Sell |
-9,419
| Closed | -$1.03M | – | 5719 |
|
|
2019
Q4 | $1.03M | Buy |
9,419
+3,449
| +58% | +$334K | ﹤0.01% | 2735 |
|
|
2019
Q3 | $618K | Buy |
5,970
+648
| +12% | +$69.6K | ﹤0.01% | 3266 |
|
|
2019
Q2 | $683K | Buy |
+5,322
| New | +$739K | ﹤0.01% | 3186 |
|
|
2019
Q1 | – | Sell |
-1,771
| Closed | -$221K | – | 5380 |
|
|
2018
Q4 | $221K | Buy |
+1,771
| New | +$303K | ﹤0.01% | 4390 |
|
|
2018
Q2 | – | Sell |
-2,395
| Closed | -$224K | – | 5359 |
|
|
2018
Q1 | $224K | Buy |
+2,395
| New | +$179K | ﹤0.01% | 4349 |
|
|
2013
Q4 | – | Sell |
-11,052
| Closed | -$297K | – | 2683 |
|
|
2013
Q3 | $297K | Buy |
+11,052
| New | +$296K | ﹤0.01% | 2099 |
|
Other funds holding MED
SCP
Jane Street's MED Position: Q2 2026 in Review
Jane Street increased its Medifast (MED) stake by 30% in Q2 2026, buying an estimated $444K and bringing the position to 164,881 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #5433.
Jane Street first reported a position in MED in Q3 2013 and has held it in 24 quarters since. The position peaked at $5.74M in Q2 2024. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.
- Jane Street held 164,881 shares of Medifast worth $1.75M as of Q2 2026.
- Jane Street bought 38,474 Medifast shares in Q2 2026, an estimated $444K.
- Medifast made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5433 holding.
- Jane Street first reported a position in Medifast in Q3 2013 and has held it in 24 quarters since.
- Jane Street's Medifast position peaked at $5.74M in Q2 2024.
- 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.